Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Bergen
Age
60–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients residing in long term nursing home units for at least 4 weeks prior to study
Diagnosed with probable or possible dementia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), FAST score \> 4
Diagnosed with depression ≥ 4 week duration as measured by CSDD ≥ 8
Written, informed consent provided by the participant (if they have capacity) or assent (if they do not have capacity) and a written proxy informed consent from a legally authorized representative empowered to make health-related decisions for the potential study participant
Clinician responsible for care, or study clinician considers that the patient suffers from any physical condition, which would make participation in the trial distressing or likely to increase suffering
Advanced severe medical disease/disorder with expected survival less than 6 months or that could interfere with participation
Psychosis or other severe mental disorder prior to dementia diagnosis
Severe aggression (≥8) on item 3 of the NPI subscale, with aggression as the predominant symptom
Schizophrenia, schizoaffective disorder and bipolar disorder
Uncontrolled epilepsy
Severe liver impairment
Renal failure
Severe injury or anaemia (Hb \< 8.5 mmol/l), comatose state, current enrolment in another experimental protocol
Known allergy or adverse reaction to paracetamol or buprenorphine transdermal patch
Advanced severe medical disease with expected survival of less than six months, severe psychiatric or neurological disorder.
Patients with diseases that make it impossible to follow the research schedule are excluded
You may not be if
The patient is contra-indicated to study drugs of pain treatment, in another trial, or had no carer.
